Nocardia farcinica IFM 10152 (nfar0)
Gene : BAD55737.1
DDBJ : putative sigma factor
Swiss-Prot:
Homologs Archaea 0/68 : Bacteria 149/915 : Eukaryota 1/199 : Viruses 0/175 --->[See Alignment]
a.177.1
a.4.13








:203 amino acids



















:SECSTR


















:PSIPRED




:DISOPRED


:BLT:PDB 13->195 1or7A PDBj 1e-07 27.4 %


:RPS:PDB 17->198 3dxjF PDBj 4e-17 12.9 %


:RPS:SCOP 26->105 1rp3A3 a.177.1.1 * 8e-11 11.4 %


:RPS:SCOP 140->196 1ku3A a.4.13.2 * 2e-08 29.8 %


:HMM:SCOP 11->129 1or7A2 a.177.1.1 * 5.5e-17 25.7 %


:HMM:SCOP 108->197 1iw7F2 a.4.13.2 * 4.6e-14 30.0 %


:RPS:PFM 145->191 PF08281 * Sigma70_r4_2 5e-06 46.8 %


:HMM:PFM 39->109 PF04542 * Sigma70_r2 2.4e-14 31.3 67/71


:HMM:PFM 144->192 PF04545 * Sigma70_r4 7.3e-14 42.9 49/50


:BLT:SWISS 4->200 RPSD_MYCTU 2e-49 50.8 %


:PROS 184->198|PS00579|RIBOSOMAL_L29
SeqInfo AminoSeq See neighboring genes
Links GIB DAD Abbreviations Back to title page
GT:ID BAD55737.1
GT:GENE BAD55737.1
GT:PRODUCT putative sigma factor
GT:DATABASE GIB00210CH01
GT:ORG nfar0
GB:ACCESSION GIB00210CH01
GB:LOCATION 993645..994256
GB:FROM 993645
GB:TO 994256
GB:DIRECTION +
GB:PRODUCT putative sigma factor
GB:PROTEIN_ID BAD55737.1
LENGTH 203
SQ:AASEQ MPLVTPGISLTMTHTGEELDLAVAAAAQGDRTALAQVLELVRPLVVRYCRARIGAAERGQLSADDVAQEVCLAVMTALPRYQDQGRPFMAFVYGIASHKVADAHRNAARNKAEAMAEVPDVISTDQGPEQRALESETSRQMNRLLATLPEKHREILVLRLVMGLSAEETAAAVGSTAGAIRVAQHRALAKLKSQVARAGEMYG
GT:EXON 1|1-203:0|
BL:SWS:NREP 1
BL:SWS:REP 4->200|RPSD_MYCTU|2e-49|50.8|197/212|
PROS 184->198|PS00579|RIBOSOMAL_L29|PDOC00501|
BL:PDB:NREP 1
BL:PDB:REP 13->195|1or7A|1e-07|27.4|175/181|
RP:PDB:NREP 1
RP:PDB:REP 17->198|3dxjF|4e-17|12.9|178/349|
RP:PFM:NREP 1
RP:PFM:REP 145->191|PF08281|5e-06|46.8|47/54|Sigma70_r4_2|
HM:PFM:NREP 2
HM:PFM:REP 39->109|PF04542|2.4e-14|31.3|67/71|Sigma70_r2|
HM:PFM:REP 144->192|PF04545|7.3e-14|42.9|49/50|Sigma70_r4|
GO:PFM:NREP 5
GO:PFM GO:0003677|"GO:DNA binding"|PF08281|IPR013249|
GO:PFM GO:0003700|"GO:transcription factor activity"|PF08281|IPR013249|
GO:PFM GO:0006352|"GO:transcription initiation"|PF08281|IPR013249|
GO:PFM GO:0006355|"GO:regulation of transcription, DNA-dependent"|PF08281|IPR013249|
GO:PFM GO:0016987|"GO:sigma factor activity"|PF08281|IPR013249|
RP:SCP:NREP 2
RP:SCP:REP 26->105|1rp3A3|8e-11|11.4|79/87|a.177.1.1|
RP:SCP:REP 140->196|1ku3A|2e-08|29.8|57/61|a.4.13.2|
HM:SCP:REP 11->129|1or7A2|5.5e-17|25.7|113/113|a.177.1.1|1/1|Sigma2 domain of RNA polymerase sigma factors|
HM:SCP:REP 108->197|1iw7F2|4.6e-14|30.0|90/105|a.4.13.2|1/1|Sigma3 and sigma4 domains of RNA polymerase sigma factors|
OP:NHOMO 235
OP:NHOMOORG 150
OP:PATTERN -------------------------------------------------------------------- -22-221211132-22222-2211322222232222333312211-------11------11116234431---------------------------------------------------------------1-311331123----------11-----------------------------------11----------------1---1----21-11-------61----------------------------------------------------------------------------------------------------------------------1----11122--1-----------2111------112121-11121-----------1-11--111--11-1---111111-111-2---------------------------------------------------------111-------------2------2-111-1---11-12-----------112---2-------------------2-1----------------------113111----------------------------------1---------------------------------------------------------------------------------------------------------------------------1---------------------------------------------1----1111----------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------1---------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
STR:NPRED 186
STR:RPRED 91.6
SQ:SECSTR ############cccHcHHHHHHHHHHHHHHHHHHHHHHHTHHHHHHHHGGGccccccTccGHHHHHHHHHHHHHHHHHcccTccccHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHcTTccHHHHHHHHHHTcccccTTcccTTcccccGGGTccccccccHHHHHHHH#####
DISOP:02AL 1-3, 7-17, 199-203|
PSIPRED cccccccccccccccHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHcccHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHccc
//